Advertisement

The Interaction of Neuromuscular Blocking Agents With Human Cholinesterases and Their Binding to Plasma Proteins

  • F. F. Foldes
  • A. Deery
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 79)

Abstract

The interactions of neuromuscular (NM) blocking agents (NMBA) with cholinesterases (ChE) have inportant pharmacologic and clinical implications. Some of the ester type NMBA, e.g., succinylcholine chloride (suxamethonium; SCh), suxethonium bromide, are hydrolyzed by human plasma butyrylcholinesterase (EC 3.1.1.8; BuChE) (Tsuji and Foldes 1953; Foldes et al. 1956). Their hydrolysis rate in most other mammalian plasmas is much lower than in human plasma (Tsuji and Foldes 1953). In vivo inhibition of plasma BuChE will increse the intensity and duration of action of hydrolyzable NMBA.

Keywords

Neuromuscular Blocking Agent Muscle AChE Succinylcholine Chloride Mammalian Plasma Pipecuronium Bromide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Deery A, Foldes FF, Benad G, McCloskey MA (1982) Interaction of neuromuscular blocking agents with human cholinesterases. Anesthesiology 51:A275CrossRefGoogle Scholar
  2. Foldes FF (1978) Enzymes of acetylcholine metabolism. In: Foldes FF (ed) Enzymes in anesthesiology. Springer, New York Heidelberg Berlin, pp 91–168CrossRefGoogle Scholar
  3. Foldes FF, Foldes VM (1965) ω-Amino fatty acid esters of choline: interaction with cholinesterases and neuromuscular activity in man. J Pharmcol Exp Ther 150:220–230Google Scholar
  4. Foldes FF, Smith JC (1966) The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis. Ann NY Acad Sci 135:287–301PubMedCrossRefGoogle Scholar
  5. Foldes FF, Swerdlow M, Lipschitz E, van Hees GR, Shanor SP (1956) Comparison of the respiratory effects of suxamethonium and suxethonium in man. Anesthesiology 17:559–568PubMedCrossRefGoogle Scholar
  6. Foldes FF, Molloy RE, Zsigmond EK, Zwartz JA (1960) Hexafluorenium: its anticholinesterase and neuromuscular activity. J Pharmacol Exp Ther 129:400–404PubMedGoogle Scholar
  7. Foldes FF, Zsigmond EK, Foldes VM, Erdos EG (1962) The distribution of acetylcholinesterase and butyrylcholinesterase in the human brain. J Neurochem 9:559–572PubMedCrossRefGoogle Scholar
  8. Foldes FF, Foldes VM, Smith JC, Zsigmond EK (1963) The relation between plasma Cholinesterase and prolonged apnea caused by succinylcholine. Anesthesiology 24:208–216PubMedCrossRefGoogle Scholar
  9. Pantuck EJ (1966) Ecothiopate iodide eye drops and prolonged response to suxamethonium. Br J Anaesth 38:406–407PubMedCrossRefGoogle Scholar
  10. Smith JC, Foldes VM, Foldes FF (1963) Distribution of Cholinesterase in normal human muscle. Can J Biochem Physiol 41:1713–1720PubMedCrossRefGoogle Scholar
  11. Tsuji FJ, Foldes FF (1953) Hydrolysis of succinylcholine in human plasma. Fed Proc 12:374Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • F. F. Foldes
  • A. Deery

There are no affiliations available

Personalised recommendations